ABSTRACT
Objetivo El objetivo de este trabajo es conocer experiencia inicial con la terapia térmica con vapor de agua (TTVA) para hiperplasia benigna de próstata (HBP) en los hospitales universitarios españoles, así como describir las diferencias en cuanto a técnica y seguimiento observadas entre los centros. Materiales y métodos Este estudio multicéntrico observacional retrospectivo recogió características basales, datos quirúrgicos, posoperatorios y seguimiento a los uno, tres, seis, 12 y 24 meses, incluyendo cuestionarios validados, variaciones flujométricas, complicaciones y la necesidad de tratamiento farmacológico y quirúrgico tras el procedimiento. También se analizaron los posibles desencadenantes de retención aguda de orina (RAO) en el posoperatorio. Resultados Se incluyeron un total de 105 pacientes. No se observaron diferencias entre los grupos con y sin RAO con respecto a tiempo de sondaje (cinco y 4,3 días respectivamente, p = 0,178), ni volumen prostático (47,9 y 41,4 g, respectivamente, p = 0,147). La mejoría media a los tres, seis, 12 y 24 meses en cuanto de flujo máximo fue de 5,3, 5,2, 4,2 y 3,8 mL/s, respectivamente. En cuanto a la eyaculación, se observa una mejoría en la misma a partir de los tres meses de seguimiento que se mantiene en el tiempo. Conclusiones El tratamiento mínimamente invasivo de HBP con TTVA presenta buenos resultados funcionales a 24 meses de seguimiento, sin afectación significativa de la función sexual y con una baja incidencia de complicaciones. Existen pequeñas variaciones principalmente en cuanto al posoperatorio inmediato entre los hospitales participantes en el estudio. (AU)
Aim The aim of this work is to evaluate the initial experience with water vapor thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) in Spanish university hospitals, as well as to describe the differences in technique and follow-up between centers. Materials and Methods This retrospective observational multicenter study collected baseline characteristics, surgical, postoperative and follow-up data at 1, 3, 6, 12 and 24 months, including validated questionnaires, flowmetric variations, complications, and the need for pharmacological or surgical treatment following the procedure. Possible triggers for postoperative acute urinary retention (AUR) were also analyzed. Results A total of 105 patients were included. No differences were observed between the groups with and without AUR with respect to catheterization time (5 and 4.3 days respectively, p = 0.178), or prostate volume (47.9 gr and 41.4 gr respectively, p = 0.147). The mean improvement at 3, 6, 12 and 24 months in terms of peak flow was 5.3, 5.2, 4.2 and 3.8 ml/s, respectively. As for ejaculation, an improvement was observed after 3 months of follow-up and was maintained over time. Conclusions Minimally invasive treatment for BPH with WVTT shows good functional outcomes at 24 months follow-up, without significant impairment of sexual function and a low incidence of complications. There are minor inter-hospital variations, mainly in the immediate postoperative period. (AU)
Subject(s)
Humans , Male , Female , Prostatic Hyperplasia/rehabilitation , Prostatic Hyperplasia/therapy , Multicenter Studies as Topic , Retrospective Studies , Prostatic Hyperplasia/drug therapy , Prostatic Hyperplasia/surgeryABSTRACT
AIM: The aim of this work is to evaluate the initial experience with water vapor thermal therapy (WVTT) for benign prostatic hyperplasia (BPH) in Spanish university hospitals, as well as to describe the differences in technique and follow-up between centers. MATERIALS AND METHODS: This retrospective observational multicenter study collected baseline characteristics, surgical, postoperative and follow-up data at 1, 3, 6, 12 and 24 months, including validated questionnaires, flowmetric variations, complications, and the need for pharmacological or surgical treatment following the procedure. Possible triggers for postoperative acute urinary retention (AUR) were also analyzed. RESULTS: A total of 105 patients were included. No differences were observed between the groups with and without AUR with respect to catheterization time (5 and 4.3 days respectively, P=.178), or prostate volume (47.9g and 41.4g respectively, P=.147). The mean improvement at 3, 6, 12 and 24 months in terms of peak flow was 5.3, 5.2, 4.2 and 3.8ml/s, respectively. As for ejaculation, an improvement was observed after 3 months of follow-up and was maintained over time. CONCLUSIONS: Minimally invasive treatment for BPH with WVTT shows good functional outcomes at 24 months follow-up, without significant impairment of sexual function and a low incidence of complications. There are minor inter-hospital variations, mainly in the immediate postoperative period.
Subject(s)
Prostatic Hyperplasia , Male , Humans , Prostatic Hyperplasia/complications , Prostatic Hyperplasia/surgery , Follow-Up Studies , Steam , Treatment Outcome , Retrospective Studies , Postoperative Complications/epidemiology , HospitalsABSTRACT
Introducción: Aunque en los últimos años la laparoscopia y los protocolos de rehabilitación multimodal Enhanced recovery after surgery (ERAS) han demostrado mejorar la recuperación postoperatoria en la cistectomía radical (CR), la eficacia clínica de su asociación aún sigue en estudio. Nuestro objetivo es analizar los posibles beneficios obtenidos de la CR laparoscópica (CRL) y su posterior combinación con ERAS (ERAS-CRL) frente a la CR abierta (CRA).Material y métodosAnalizamos 187CR consecutivas con derivación urinaria heterotópica realizadas en nuestro centro, de las cuales 139 cumplieron los criterios de inclusión: 47CRA, 39CRL (ambas con protocolo convencional) y 52 ERAS-CRLResultadosNo se encontraron diferencias significativas en cuanto a edad, sexo, IMC y ASA entre los 3 grupos. ERAS-CRL obtuvo una estancia hospitalaria más corta que CRL y CRA (mediana 8 [7-10]) vs. 13 [10-17] vs. 15 [13-19,5] días, respectivamente; p<0,001). ERAS-CRL también tuvo una estancia más corta en la UCI y menos días de sonda nasogástrica (p<0,001). Las complicaciones postoperatorias y los reingresos fueron similares en los 3 grupos. La ausencia de complicaciones, una edad más joven y ERAS fueron factores independientes relacionados con una menor estancia hospitalaria, mientras que ERAS fue el único factor independiente asociado con un menor reingreso a los 90 días.ConclusionesAunque la CRL presentó beneficios perioperatorios respecto a la CRA, los resultados fueron mejores tras la implementación de un programa ERAS, siendo el impacto de este último más importante que la técnica quirúrgica utilizada. (AU)
Introduction: Although in the recent years, laparoscopy and Enhanced Recovery After Surgery (ERAS) protocols have improved postoperative recovery in radical cystectomy (RC), the clinical efficacy of their association remains unclear. Our objective is to analyze the possible benefits obtained from laparoscopic RC (LRC) and its subsequent combination with an ERAS (ERAS-LRC) protocol compared to open RC (ORC).Material and methodsWe analyzed 187 consecutive RCs with ileal conduit performed in our center, of which 139 met the inclusion criteria: 47 ORC, 39 LRC (both with conventional protocol) and 52 ERAS-LRCs.ResultsNo significant differences were found regarding age, sex, BMI and ASA score between groups. ERAS-LRC obtained a shorter length of stay than LRC and ORC (median 8 [7-10]) vs. 13 [10-17] vs. 15 [13-19.5] days, respectively; P<.001). ERAS-LRC had a shorter stay in the ICU and less days of nasogastric tube (P<.001). Postoperative complications and readmission rates were similar among groups. Multivariate logistic regression showed that absence of complications, younger age and ERAS behaved as independent factors for shorter hospital stay, while ERAS was the only independent factor of lower readmission rate at 90 days.ConclusionsAlthough LRC presented perioperative benefits compared to ORC, the results were better after the implementation of an ERAS protocol. ERAS protocol had stronger impact on recovery than the surgical approach of the procedure. (AU)
Subject(s)
Humans , Cystectomy/adverse effects , General Surgery , Laparoscopy , Urinary Bladder Neoplasms , Retrospective StudiesABSTRACT
INTRODUCTION: Although in the recent years, laparoscopy and Enhanced Recovery After Surgery (ERAS) protocols have improved postoperative recovery in radical cystectomy (RC), the clinical efficacy of their association remains unclear. Our objective is to analyze the possible benefits obtained from laparoscopic RC (LRC) and its subsequent combination with an ERAS (ERAS-LRC) protocol compared to open RC (ORC). MATERIAL AND METHODS: We analyzed 187 consecutive RCs with ileal conduit performed in our center, of which 139 met the inclusion criteria: 47 ORC, 39 LRC (both with conventional protocol) and 52 ERAS-LRCs. RESULTS: No significant differences were found regarding age, sex, BMI and ASA score between groups. ERAS-LRC obtained a shorter length of stay than LRC and ORC (median 8 [7-10]) vs. 13 [10-17] vs. 15 [13-19.5] days, respectively; P<.001). ERAS-LRC had a shorter stay in the ICU and less days of nasogastric tube (P<.001). Postoperative complications and readmission rates were similar among groups. Multivariate logistic regression showed that absence of complications, younger age and ERAS behaved as independent factors for shorter hospital stay, while ERAS was the only independent factor of lower readmission rate at 90 days. CONCLUSIONS: Although LRC presented perioperative benefits compared to ORC, the results were better after the implementation of an ERAS protocol. ERAS protocol had stronger impact on recovery than the surgical approach of the procedure.
Subject(s)
Enhanced Recovery After Surgery , Laparoscopy , Urinary Bladder Neoplasms , Urinary Diversion , Cystectomy/adverse effects , Humans , Retrospective Studies , Urinary Bladder Neoplasms/surgeryABSTRACT
Introducción: La disfunción eréctil peneana tiene una prevalencia alta entre los 40-70 años, por lo que es importante su valoración basal antes de la prostatectomía radical. Material y métodos: Se ha evaluado la función eréctil (FE) de 112 pacientes con cáncer de próstata previamente a la prostatectomía radical, mediante el dominio de la FE del Índice Internacional de Función Eréctil (IIEF), el test Erectile Hardness Score (EHS) y una ecografía doppler de pene (EDP). Se recogieron comorbilidades, el índice de Charlson y se administró el test de calidad de vida de la EORTC QLQ C-30 y PR-25. Resultados: Un 50,9% de la población tenían una FE normal usando el cuestionario IIEF y un 75,9% conseguían una erección grado 3-4 en el EHS. Únicamente el 28,6% presentaban una EDP normal, y el 51,8% mostraron insuficiencia arterial. Encontramos una asociación significativa (p < 0,0001) entre el IIEF categorizado y el valor de EHS. Se encontró una asociación significativa (p = 0,005) entre la presencia en la EDP (normal vs. patológico) y el EHS (3-4 vs. 1-2). Solo el 35,3% de los pacientes con un EHS de 3-4 tenían una EDP normal. También encontramos una asociación significativa (p = 0,043) entre la EDP y la FE valorada según el IIEF (≥ 26vs.< 26). Únicamente tenían una EDP normal el 38,6% de los pacientes con IIEF ≥ 26. Conclusiones: Es importante una valoración global de la FE para poder valorar las expectativas de recuperación de dicha función tras la cirugía y no reducirla únicamente a test autoadministrados, pudiendo jugar un papel importante la EDP
Introduction: Given the high prevalence of erectile dysfunction in male population between 40-70 years old and the effect of radical prostatectomy on this domain, it is important to perform a baseline study. Material and methods: Prior radical prostatectomy, erectile function has been assessed prospectively in 112 prostate cancer patients using the erectile function (EF) domain of the International Index of Erectile Function (EF-IIEF), Erectile Hardness Score (EHS) and a penile doppler ultrasound (PDUS). Comorbidities and Charlson index were collected. The EORTC QLQ C-30 and PR-25 tests were administered. Results: According to EF-IIEF questionnaire, 50.9% of patients showed normal EF and EHS grade 3-4 erection was achieved in the 75.9%. PDUS was normal only in 28.6% of patients and 51.8% showed arterial insufficiency. We found a significant association (P < .0001) between categorized EF-IIEF (normal, mild/moderate/severe) and the EHS value. Between PDUS (normal vs. pathologic) and EHS (3-4 vs. 1-2) statistically significant association (P = .005) was found. Just 35.3% of patients with EHS 3-4 showed normal PDUS. Correlation between the PDUS and the EF-IIEF (≥2 6 vs.< 26) was statistically significant (P = .043). Moreover, only 38.6% of patients with EF-IIEF ≥ 26 had a normal PDUS. Conclusions: In order to predict EF recovery after surgery, global assessment is required. Solely self-administered tests are not enough. In this baseline study, PDUS can play an important role
Subject(s)
Humans , Male , Middle Aged , Aged , Prostatic Neoplasms/diagnostic imaging , Prostatic Neoplasms/surgery , Prostatectomy/methods , Quality of Life , Ultrasonography, Doppler , Erectile Dysfunction , Prospective Studies , Surveys and Questionnaires , Adrenergic beta-AntagonistsABSTRACT
INTRODUCTION: Given the high prevalence of erectile dysfunction in male population between 40-70 years old and the effect of radical prostatectomy on this domain, it is important to perform a baseline study. MATERIAL AND METHODS: Prior radical prostatectomy, erectile function has been assessed prospectively in 112 prostate cancer patients using the erectile function (EF) domain of the International Index of Erectile Function (EF-IIEF), Erectile Hardness Score (EHS) and a penile doppler ultrasound (PDUS). Comorbidities and Charlson index were collected. The EORTC QLQ C-30 and PR-25 tests were administered. RESULTS: According to EF-IIEF questionnaire, 50.9% of patients showed normal EF and EHS grade 3-4 erection was achieved in the 75.9%. PDUS was normal only in 28.6% of patients and 51.8% showed arterial insufficiency. We found a significant association (P<.0001) between categorized EF-IIEF (normal, mild/moderate/severe) and the EHS value. Between PDUS (normal vs. pathologic) and EHS (3-4 vs. 1-2) statistically significant association (P=.005) was found. Just 35.3% of patients with EHS 3-4 showed normal PDUS. Correlation between the PDUS and the EF-IIEF (≥26 vs.<26) was statistically significant (P=.043). Moreover, only 38.6% of patients with EF-IIEF≥26 had a normal PDUS. CONCLUSIONS: In order to predict EF recovery after surgery, global assessment is required. Solely self-administered tests are not enough. In this baseline study, PDUS can play an important role.